tenofovir
tenofovir is a pharmaceutical drug with 75 clinical trials. Currently 1 active trials ongoing. Historical success rate of 82.3%.
Success Metrics
Based on 51 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
16
Mid Stage
36
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.5%
51 of 65 finished
21.5%
14 ended early
1
trials recruiting
75
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Clinical Trials (75)
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus
Using Flavonoids to Kill Hepatitis B Virus
From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract
Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC
Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention
Effect on HIV Medications on EPC Cells
Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV
Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel
Test Albuvirtide in Experienced Patients
Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 75